Skip to main content
Erschienen in: Indian Journal of Pediatrics 8/2016

26.02.2016 | Original Article

Predictors of Mortality and Mortality Rate in a Cohort of Children Living with HIV from India

verfasst von: G. N. Sanjeeva, Pooja Gujjal Chebbi, H. B. Pavithra, M. Sahana, D. R. Sunil Kumar, Lalitha Hande

Erschienen in: Indian Journal of Pediatrics | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To study the predictors of mortality and mortality rate in a clinical cohort of Children Living with Human Immunodeficiency Virus infection (CLHIV) from India.

Methods

This retrospective cohort analysis of CLHIV aged between 2 mo and 18 y registered during January 2004 through December 2014 at Pediatric Centre of Excellence (PCOE), Indira Gandhi Institute of Child Health (IGICH), was conducted using standard data collection sheet. Demographic and clinical characteristics of all eligible children were analyzed. The primary outcome measured was mortality. The authors also analyzed the cause of death and baseline parameters associated with death to study the predictors of mortality.

Results

Out of 1289 CLHIV registered in the PCOE during the study period, 834 (64.7 %) CLHIV, with or without antiretroviral therapy (ART) care, were included. The total time contributed by the study participants was 2872.8 child-years. The mortality rate in these children was 4.9/100 child-years. A significantly higher mortality rate of 28.2 % was found in children < 5 y, 38.6 % in children with advanced WHO clinical staging, 35.2 % among severely immunosuppressed children and 22.3 % in severely malnourished children. Tuberculosis accounted for 28 % of deaths. Univariate Cox regression analysis showed treatment status, age <5 y, baseline WHO clinical stage 3 and 4, severe immune suppression and severe malnutrition were strongly associated with mortality.

Conclusions

The mortality rate in the index study cohort was 4.9/100 child-years and tuberculosis was the major cause of death. Younger age, baseline advanced clinical and immunological staging were predictors of mortality. Even though mortality was significantly higher in Pre-ART children, treatment status was not found to be an independent predictor of mortality.
Literatur
4.
Zurück zum Zitat Chearskul S, Chotpitayasunondh T, Simonds RJ, et al; Bangkok Collaborative Perinatal HIV Transmission Study Group. Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics. 2002;110:e25.CrossRefPubMed Chearskul S, Chotpitayasunondh T, Simonds RJ, et al; Bangkok Collaborative Perinatal HIV Transmission Study Group. Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics. 2002;110:e25.CrossRefPubMed
5.
Zurück zum Zitat Villamor E, Misegades L, Fataki MR, Mbise RL, Fawzi WW. Child mortality in relation to HIV infection, nutritional status, and socio-economic background. Int J Epidemiol. 2005;34:61–8.CrossRefPubMed Villamor E, Misegades L, Fataki MR, Mbise RL, Fawzi WW. Child mortality in relation to HIV infection, nutritional status, and socio-economic background. Int J Epidemiol. 2005;34:61–8.CrossRefPubMed
6.
Zurück zum Zitat Obimbo EM, Mbori-Ngacha DA, Ochieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J. 2012;23:536–43.CrossRef Obimbo EM, Mbori-Ngacha DA, Ochieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J. 2012;23:536–43.CrossRef
7.
Zurück zum Zitat Okomo U, Togun T, Oko F, Peterson K, Jaye A. Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa. AIDS Res Ther [Internet]. 2012;9:28.CrossRef Okomo U, Togun T, Oko F, Peterson K, Jaye A. Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa. AIDS Res Ther [Internet]. 2012;9:28.CrossRef
8.
Zurück zum Zitat Ebonyi AO, Oguche S, Meloni ST, et al. Predictors of mortality in a clinic cohort of HIV-1 infected children initiated on antiretroviral therapy in Jos, Nigeria. J AIDS Clin Res. 2014;5:403. doi:10.4172/2155-6113.1000403. Ebonyi AO, Oguche S, Meloni ST, et al. Predictors of mortality in a clinic cohort of HIV-1 infected children initiated on antiretroviral therapy in Jos, Nigeria. J AIDS Clin Res. 2014;5:403. doi:10.​4172/​2155-6113.​1000403.
9.
Zurück zum Zitat Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Cote d’Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490–9.CrossRefPubMed Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Cote d’Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490–9.CrossRefPubMed
10.
Zurück zum Zitat Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS One. 2011;6:e22706.CrossRefPubMedPubMedCentral Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS One. 2011;6:e22706.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:33.CrossRefPubMedPubMedCentral Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:33.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Fenner L, Brinkhof MWG, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524–32.CrossRefPubMedPubMedCentral Fenner L, Brinkhof MWG, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524–32.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, Moore CB, Moss WJ. Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children. AIDS Res Hum Retrovir. 2013;29:479–87.CrossRefPubMedPubMedCentral Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, Moore CB, Moss WJ. Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children. AIDS Res Hum Retrovir. 2013;29:479–87.CrossRefPubMedPubMedCentral
Metadaten
Titel
Predictors of Mortality and Mortality Rate in a Cohort of Children Living with HIV from India
verfasst von
G. N. Sanjeeva
Pooja Gujjal Chebbi
H. B. Pavithra
M. Sahana
D. R. Sunil Kumar
Lalitha Hande
Publikationsdatum
26.02.2016
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 8/2016
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2047-9

Weitere Artikel der Ausgabe 8/2016

Indian Journal of Pediatrics 8/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.